Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

NCT03952832 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Budget issues

Conditions

Interventions

Sponsor

City of Hope Medical Center

Collaborators